Lyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalysts
CIPhotos Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) stock price has risen by >20% year to date and >45% across the past 12 months. The stock has been moderately volatile, reaching highs of >$3 in early March, and at the end of last week, before …